腺癌
细胞周期
基因沉默
癌基因
免疫组织化学
癌症研究
细胞生长
细胞凋亡
肺
临床意义
生物
细胞
医学
病理
癌症
内科学
免疫学
基因
遗传学
作者
Hongying Wang,Yiming Liang,Ze Xing,Hanqing Li,Tangfeng Lv,Hongbing Liu,Fang Zhang,Yong Song
标识
DOI:10.1016/j.prp.2019.152559
摘要
CDCA7 is overexpressed in several malignant cancers and is predicted by bioinformatics to be a candidate oncogene in lung adenocarcinoma (LUAD). However, the clinical and biological function of CDCA7 in LUAD has never been investigated. In this study, we used quantitative real-time RT-PCR and immunohistochemistry to determine the expression level and clinical significance of CDCA7. As a result, CDCA7 was significantly overexpressed in LUAD compared to adjacent normal tissues. Furthermore, overexpression of CDCA7 was positively associated with more advanced clinical features. Silencing CDCA7 inhibited cell proliferation in LUAD through G1 phase arrest and induction of apoptosis. In conclusion, CDCA7 can be used as a potential therapeutic target for new biomarkers and LUAD.
科研通智能强力驱动
Strongly Powered by AbleSci AI